MARKET

IHE

IHE

iShares US Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

181.10
+1.03
+0.57%
Closed 16:00 05/07 EDT
OPEN
180.23
PREV CLOSE
180.08
HIGH
181.91
LOW
180.23
VOLUME
2.86K
TURNOVER
--
52 WEEK HIGH
188.10
52 WEEK LOW
145.27
TOTAL ASSET
358.26M
YTD YIELD
3.26%
1D
5D
1M
3M
1Y
5Y
House Democrats reintroduce bill to lower drug prices
Rep. Frank Pallone, Jr. (D-N.J.) reintroduced H.R. 3, legislation that would allow the federal government to negotiate prescription drug prices.The bill would cap seniors' out-of-pocket costs on prescription drugs to
Seekingalpha · 04/22 19:47
Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results
Zacks.com · 04/21 06:40
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?
Zacks.com · 04/15 09:02
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update
Zacks.com · 03/31 22:17
iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.6348
iShares U.S. Pharmaceuticals ETF (IHE) - $0.6348.30-Day SEC Yield of 1.34% as of Feb. 26.Payable Mar 31; for shareholders of record Mar 26; ex-div Mar 25.
Seekingalpha · 03/25 18:36
Niche ETFs Are Winning Over Chinese Investors
There are more thematic exchange-traded funds than broad index ETFs for the first time since China’s ETF market started in 2003.
Bloomberg · 03/22 21:00
Bond Dip Buyers Emerge After Treasury Selloff Hits Record Speed
Bloomberg · 03/22 19:52
Death of a Treasury Bull Market Rocks Faith in Market Winners
Stocks may be catching a breather in Monday trading, but the aftershocks from the sharpest bond selloff in almost five decades are set to reverberate across investing strategies hitched to the cheap-money era.
Bloomberg · 03/22 16:11
More
No Data
Learn about the latest financial forecast of IHE. Analyze the recent business situations of iShares US Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.3778%
--
1-Week
-0.8453%
--
1-Month
1.9367%
--
3-Month
4.0582%
--
6-Month
12.6868%
--
YTD
3.2634%
--
1-Year
19.5234%
--
3-Year
3.2315%
--
5-Year
1.4765%
--
10-Year
12.4567%
--
Since Inception
10.1687%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
iShares US Pharmaceuticals ETF
Risk
Medium-low risk
Inception Date
2006-05-01
Benchmark
Dow Jones US Healthcare TR
Advisor Company
iShares
Custodian
State Street Bank & Trust Co
Manager
Team Managed